| | RA | UA | ReA | Gout | Ps-gout | PsA | OA | Sarc | SpA | RS3PE | Other |
|---|
anti-CarP | 44 % | 10 % | 16 % | 8 % | 0 % | 9 % | 11 % | 9 % | 15 % | 4 % | 17 % |
anti-CCP2 | 54 % | 3 % | 8 % | 0 % | 0 % | 6 % | 7 % | 5 % | 8 % | 0 % | 7 % |
IgM-RF | 59 % | 5 % | 7 % | 6 % | 11 % | 10 % | 20 % | 7 % | 4 % | 7 % | 20 % |
- The percentages indicate the proportion of patients positive for one of the three autoantibodies analyzed in all samples available for each of the diagnoses
-
Anti-CarP Anti-carbamylated protein, Anti-CCP2 Anti-cyclic citrullinated peptide 2, IgM-RF Immunoglobulin M-rheumatoid factor, OA Inflammatory osteoarthritis, PsA Psoriatic arthritis, Ps-Gout Pseudogout, RA Rheumatoid arthritis, ReA Reactive arthritis (bacterial and viral), RS3PE Remitting seronegative symmetrical synovitis with pitting edema, Sarc Sarcoidosis, SpA Spondylarthropathy with peripheral arthritis, UA Undifferentiated arthritis
